Aurinia Pharmaceuticals
AUPH
$5.10
Share price
-1.26%
Change (1 day)
-55.92%
Change (1 year)
Categories
Aurinia Pharmaceuticals (AUPH) - Total debt
Total debt on the balance sheet as of December 2023 : $97.6 M
According to Aurinia Pharmaceuticals 's latest financial reports the company's total debt is $97.6 M. A company’s total debt is the sum of all current and non-current debts.
Aurinia Pharmaceuticals - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $97.6 M | 1106.81% |
| 2022-12-31 | $8.08 M | -7.45% |
| 2021-12-31 | $8.73 M | 3.95% |
| 2020-12-31 | $8.4 M | |
| 2019-12-31 | $N/A | |
| 2013-12-31 | $N/A | -100% |
| 2012-12-31 | $0.03 M | -54.39% |
| 2011-12-31 | $0.07 M | |
| 2008-12-31 | $12.88 M | 1770.37% |
| 2007-12-31 | $0.68 M | -70.5% |
| 2006-12-31 | $2.33 M | -41.11% |
| 2005-12-31 | $3.96 M | -18.62% |
| 2004-12-31 | $4.87 M | 1046.46% |
| 2003-12-31 | $0.42 M | 63.55% |
| 2002-12-31 | $0.25 M | 102.74% |
| 2001-12-31 | $0.12 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | $2.70 B | 2,669.17% | 🇺🇸 USA |
 Pieris Pharmaceuticals PIRS | $12.29 M | -87.41% | 🇺🇸 USA |
 Aeterna Zentaris AEZS | $0.27 M | -99.71% | 🇺🇸 USA |